AstraZeneca Pharma India Statistics
Total Valuation
BOM:506820 has a market cap or net worth of INR 223.46 billion. The enterprise value is 218.45 billion.
Market Cap | 223.46B |
Enterprise Value | 218.45B |
Important Dates
The next estimated earnings date is Friday, November 14, 2025.
Earnings Date | Nov 14, 2025 |
Ex-Dividend Date | Jul 18, 2025 |
Share Statistics
BOM:506820 has 25.00 million shares outstanding. The number of shares has increased by 0.05% in one year.
Current Share Class | 25.00M |
Shares Outstanding | 25.00M |
Shares Change (YoY) | +0.05% |
Shares Change (QoQ) | +0.01% |
Owned by Insiders (%) | 8.02% |
Owned by Institutions (%) | 7.31% |
Float | 4.14M |
Valuation Ratios
The trailing PE ratio is 121.90.
PE Ratio | 121.90 |
Forward PE | n/a |
PS Ratio | 12.05 |
PB Ratio | 29.01 |
P/TBV Ratio | 29.03 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 119.14 |
EV / Sales | 11.78 |
EV / EBITDA | 75.53 |
EV / EBIT | 89.09 |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 0.05 |
Debt / EBITDA | 0.12 |
Debt / FCF | n/a |
Interest Coverage | 118.45 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | 20.13% |
Return on Capital Employed (ROCE) | n/a |
Revenue Per Employee | 23.13M |
Profits Per Employee | 2.29M |
Employee Count | 802 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, BOM:506820 has paid 628.60 million in taxes.
Income Tax | 628.60M |
Effective Tax Rate | 25.53% |
Stock Price Statistics
The stock price has increased by +36.35% in the last 52 weeks. The beta is 0.11, so BOM:506820's price volatility has been lower than the market average.
Beta (5Y) | 0.11 |
52-Week Price Change | +36.35% |
50-Day Moving Average | 8,869.10 |
200-Day Moving Average | 8,132.74 |
Relative Strength Index (RSI) | 51.70 |
Average Volume (20 Days) | 1,013 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:506820 had revenue of INR 18.55 billion and earned 1.83 billion in profits. Earnings per share was 73.33.
Revenue | 18.55B |
Gross Profit | 8.21B |
Operating Income | 2.45B |
Pretax Income | 2.46B |
Net Income | 1.83B |
EBITDA | 2.84B |
EBIT | 2.45B |
Earnings Per Share (EPS) | 73.33 |
Balance Sheet
The company has 5.36 billion in cash and 357.30 million in debt, giving a net cash position of 5.00 billion or 200.16 per share.
Cash & Cash Equivalents | 5.36B |
Total Debt | 357.30M |
Net Cash | 5.00B |
Net Cash Per Share | 200.16 |
Equity (Book Value) | 7.70B |
Book Value Per Share | 308.14 |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 44.27%, with operating and profit margins of 13.22% and 9.88%.
Gross Margin | 44.27% |
Operating Margin | 13.22% |
Pretax Margin | 13.27% |
Profit Margin | 9.88% |
EBITDA Margin | 15.33% |
EBIT Margin | 13.22% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 32.00, which amounts to a dividend yield of 0.35%.
Dividend Per Share | 32.00 |
Dividend Yield | 0.35% |
Dividend Growth (YoY) | 33.33% |
Years of Dividend Growth | 3 |
Payout Ratio | n/a |
Buyback Yield | -0.05% |
Shareholder Yield | 0.30% |
Earnings Yield | 0.82% |
FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
The last stock split was on June 15, 2006. It was a forward split with a ratio of 5.
Last Split Date | Jun 15, 2006 |
Split Type | Forward |
Split Ratio | 5 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |